Companion Animal News: November 24, 2025
Vivos, Exubrion to cooperate on targeted radioactive isotope therapy for pets
Radiotherapeutic firms Vivos Inc. and Exubrion Therapeutics announced they will broaden their shared efforts in clinic relationships, licensing coordination and manufacturing. These initiatives build upon prior collaboration in device classification and development of clinician training modules. “Exubrion’s focus on treating osteoarthritis pain in companion animals and Vivos’s work in cancer therapy represent distinct markets, enabling collaboration without competitive conflict,” said Vivos CEO Dr. Michael Korenko.
American Association of Veterinary Medical Colleges names Dr. Emma Read CEO
The American Association of Veterinary Medical Colleges appointed Emma Read, DVM, of The Ohio State University as chief executive officer. A graduate of the Western College of Veterinary Medicine in Saskatoon, Saskatchewan, Dr. Read has served since 2018 as associate dean for professional programs at Ohio State’s College of Veterinary Medicine, where she recently led a comprehensive curricular redesign.
The rise of pet genetics
When consumer genetic testing became popularized by companies such as 23andMe and AncestryDNA, few could envision how fast the technology would spread to the animal world. However, with the lowering of sequencing prices and the expansion of databases, scientists have discovered the same could be used in pets.
BioVenic launches platform for immune cell therapies for veterinary medicine
Biovenic announced it is providing tailored solutions — veterinary CAR-T therapy development — to tackle challenges in developing immune cell therapies for canine lymphoma, feline leukemia and even emerging zoonotic cancers. Unlike most veterinary CAR programs, which retrofit human constructs, Biovenic’s designed CAR cells are said to be tailored to animal immune systems, with customized antigen recognition domains and co-stimulatory signals that enhance targeting precision.
CoVet says its in-app feature provides real-time clinical decision support to vets
AI scribe tool CoVet has introduced Consult CoVet, a new feature within the CoVet app powered by LifeLearn Animal Health’s Sofie AI. Consult CoVet is said to provide real-time clinical decision support directly on the case page, helping veterinarians explore differentials and review treatment considerations without ever leaving their workflow.
Elanco, Alloy Partners create One Health venture studio
Venture builder Alloy Partners, in partnership with Elanco Animal Health, announced the launch of OneHealth Studio, a venture studio designed to create and scale companies at the convergence of animal, plant and human health. Located in the OneHealth Innovation District at Elanco’s global headquarters in Indianapolis, the studio is intended to unite research institutions, investors, corporate partners and entrepreneurs to launch new startups based in Indiana.
Animal Neurology Center is first site in US to install Siemens’ new MRI
Animal Neurology Center in St. Louis, Missouri, reported completing its installation of the Siemens Magnetom Flow.Ace MRI. Practice CEO Dr. Fred Wininger said the manufacturer’s decision to “debut its most advanced technology in a veterinary hospital [is a recognition of] the growing respect for veterinary medicine’s sophistication and impact.”
AVMA Agrees to Delay Hearing Following Tuskegee University Lawsuit
After filing a federal lawsuit on Nov. 10 to delay an accreditation appeal hearing with the AVMA, Tuskegee University announced that the AVMA has agreed to “reconsider its procedures.” This change will allow the only historically Black veterinary program in the country to prepare evidence of improvements made since the AVMA made a campus visit in 2021. “This reconsideration is an important step toward ensuring that decisions affecting our University students and faculty are made through clear, accountable, and fair processes,” said a university spokesperson in a statement to Yellowhammer News.
